The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 18,921 | 1,153,022 | SH | SOLE | 1,153,022 | 0 | 0 | ||
REALTY INCOME CORP | COM | 756109104 | 214 | 3,200 | SH | SOLE | 3,200 | 0 | 0 | ||
TIER REIT INC | COM NEW | 88650V208 | 463 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
None | None | None | 0 | 0 | SH | SOLE | 0 | 0 | 0 |